Anheuser-Busch InBev refocuses on North America, shares stay in line with global brewers

Anheuser-Busch InBev is reshaping its North American strategy while investors track how the world’s largest brewer performs against peers like Heineken and Carlsberg. Consensus still points to modest earnings growth after a volatile 2023 in the US.

By Stefan Krueger, Long-Term & Business Model desk. Reviewed prior to publication on 2026-06-24, 07:25.

Anheuser-Busch InBev (BE0974293251) remains under close watch as the world’s largest brewer adjusts its long-term strategy, with investors comparing its performance to peers like Heineken and Carlsberg on major venues such as Euronext and the NYSE.

Long-term strategy after the Bud Light setback

AB InBev has spent the past year responding to the Bud Light boycott in the United States, which significantly hit its US sales in 2023 and forced a strategic rethink in its key North American market, according to a detailed Reuters analysis of its US performance. Management has emphasized a focus on rebuilding the Bud Light brand, strengthening relationships with distributors, and reallocating marketing spend towards core labels and sports partnerships in the region.

In parallel, AB InBev is doubling down on high-margin premium and super-premium offerings globally, areas where it sees structural growth opportunities even as mainstream volumes in some mature markets remain flat. This approach mirrors the strategic direction taken by competitors like Heineken and Carlsberg, which are also concentrating on premiumization and cost efficiencies in their worldwide operations.

Analyst consensus points to moderate earnings growth

Analyst consensus for AB InBev continues to suggest modest earnings growth over the next 12 to 24 months, with several major houses expecting that North American headwinds will gradually ease while Latin America and Asia provide incremental support to group profitability, according to a recent Financial Times overview of the global brewing sector. The company’s strong presence in emerging markets, including Brazil and other parts of Latin America, underpins these medium-term expectations.

Major European and US-listed brewers are being evaluated together by fund managers who compare AB InBev’s valuation and growth profile with that of Heineken, Carlsberg and Molson Coors, taking into account regional exposure and brand portfolios. For long-term investors, the debate centers on how quickly AB InBev’s US volumes can stabilize and whether its premiumization strategies can offset short-term volatility in mature markets.

The brands and products that drive earnings

AB InBev generates cash flow through a broad portfolio of beer and beyond-beer brands that target various price points and regional tastes. Global flagship labels such as Budweiser, Stella Artois and Corona provide international recognition, while local champions like Skol, Brahma and Quilmes underpin market share in specific countries and regions.

Premium and super-premium offerings, including brands such as Stella Artois and Corona, typically earn higher margins than mainstream beers and are central to the company’s long-term strategic emphasis. Non-beer beverages, including flavored malt beverages and other ready-to-drink products, complement the core beer lineup and provide additional revenue streams.

Where the stock trades and current price snapshot

The Anheuser-Busch InBev shares (BE0974293251) trade primarily on Euronext Brussels under the ticker ABI, and at the last verified price on 2026-06-24, 09:00 they changed hands at 62.50 euros.

Key data on the Anheuser-Busch InBev shares

• Company: Anheuser-Busch InBev SA/NV
• ISIN: BE0974293251
• WKN: A2ASUV
• Ticker: ABI
• Trading venue: Euronext Brussels
• Price (as of 2026-06-24, 09:00): 62.50 euros
• Market cap: 108.0 billion euros (as of 2026-06-24)
• Sector / industry: Consumer Staples / Beverages / Brewers
• Index membership: BEL 20, STOXX Europe 600
• Next earnings date: not officially scheduled

This article is for informational purposes only and does not constitute investment advice, an offer, or a solicitation to buy or sell any securities.